Latest
By Staff Report / Wednesday, August 12th, 2015 / Latest news, Tri-County Public Companies / Comments Off on Thousand Oaks’ Ceres sees stock price spike after patent approved
Ceres, a Thousand Oaks based agriculture-biotechnology company, saw shares spike 373 percent Wednesday after the company received a patent for its iCODE multi-gene trait development system. Ceres shares started the day at just 95 cents per share, and soared all the way to $4.80 when the markets opened at 6:30 a.m. PST. Ceres closed the Read More →
Read More →
Latest
By Staff Report / Monday, August 10th, 2015 / Earnings, Latest news, Technology, Tri-County Public Companies / Comments Off on Revenues down but Thousand Oaks-based Teledyne beats estimates
Thousand Oaks-based Teledyne Technologies beat analyst estimates when it reported second-quarter earnings on July 30 but the company still saw a sharp decline in net income. Teledyne posted earnings of $1.34 per share, barely beating analyst estimates of $1.33 per share. Second-quarter revenues were down by 3.2 percent from the second-quarter of 2014, from $597.1 Read More →
Read More →
Latest
By Henry Dubroff / Friday, August 7th, 2015 / Central Coast Health Watch, Columns, Tri-County Economy / Comments Off on Dubroff: Washington dysfunction over taxes could cost jobs in Tri-Counties
This is a column about how dysfunction in Washington is handing billions over to Wall Street while threatening thousands of jobs on the Central Coast. Just a year ago, Allergan shut its Goleta breast implant operation after it came under siege from corporate raiders, Activis, a New Jersey-based company that used an acquisition in Ireland Read More →
Read More →
Latest
By Staff Report / Tuesday, August 4th, 2015 / Central Coast Health Watch, Latest news, Technology, Top Stories, Tri-County Public Companies / Comments Off on Shire makes $30 billion bid for Thousands Oaks’ Baxalta
One of the biggest employers in Ventura County faces an ownership change less than one month after it was spun off from its Chicago-area parent. Shire Plc, a pharma company based in Dublin, Ireland, stunned the markets on Aug. 4 with a $30 billion bid for Baxalta. Baxalta, which employs around 2,000 at two locations Read More →
Read More →
Latest
By Staff Report / Thursday, July 30th, 2015 / Latest news, Technology, Top Stories, Tri-County Public Companies / Comments Off on Amgen second-quarter profit beats analysts’ estimates
Thousand Oaks-based Amgen Inc. posted second-quarter profit that topped analysts’ estimates, driven by higher sales and lower operating expenses. The biotech also raised its revenue and earnings forecast for the year. Profit excluding one-time items rose to $2.57 a share, while analysts had predicted $2.43 on average. Revenue increased 3.7 percent to $5.37 billion, the Read More →
Read More →
Latest
By Staff Report / Thursday, July 23rd, 2015 / Central Coast Health Watch, Latest news, Technology, Top Stories, Tri-County Public Companies / Comments Off on Amgen submits data on cancer drug Kyprolis to FDA
Thousand Oaks-based Amgen announced Thursday that it submitted data comparing its new multiple-myeloma drug against a rival to the Food and Drug Administration. Kyprolis is Amgen’s new treatment for multiple-myeloma, which is a form of blood cancer that forms in plasma cells and typically grows in bone marrow. The drug was approved for third-line treatments Read More →
Read More →
Latest
By Staff Report / Monday, July 20th, 2015 / Latest news, Technology, Top Stories, Tri-County Public Companies / Comments Off on Thousand Oaks-based Teledyne wins $15 million contract from NASA
Teledyne Technologies won an out of this world contract Tuesday. Thousand Oaks-based Teledyne announced that it won a $15 million contract from NASA on Monday to build a hyper-spectral remote sensing imaging instrument that will be used on the International Space Station. Teledyne makes instrumentation, digital imaging products and software for aerospace and defense systems. Read More →
Read More →
